News

Sweet Marjoram Tea May Lessen Non-motor Symptoms

Daily consumption of sweet marjoram tea, in addition to standard antiparkinsonian medication, may help reduce non-motor symptoms and depression in people with Parkinson’s disease, a small study suggests. Notably, the one-month intervention, while safe, was found to have no significant effect on patients’ motor symptoms, even though they showed…

B-SOiD Algorithm May Make it Easier to Study Behavior

A novel machine learning algorithm called B-SOiD quickly and efficiently analyzes animal behaviors, and may be useful in assessing movement disorders in people with Parkinson’s disease. Researchers described their findings in the study, “B-SOiD, an open-source unsupervised algorithm for identification and fast prediction of behaviors,” published in Nature…

Many Patients Harbor Misconceptions About Vaccines

Many people with Parkinson’s disease have misconceptions about routine vaccinations, with more than one of 10 patients thinking they are not recommended for people with Parkinson’s — even though they very much are, as they can be life-saving. The results, based on a survey of patients in the U.S.,…

Transcranial Stimulation With Exercise May Boost Benefits for Patients

Transcranial stimulation — a noninvasive procedure that sends low-level electric currents to certain brain regions — may boost the benefits of aerobic exercise and improve gait for people with idiopathic Parkinson’s disease, a small study reports. “We found that transcranial stimulation activated the pre-frontal cortex, a brain region that Parkinson’s…

Virtual Reality Games Take Aim at Trunk Control in Parkinson’s

A Virginia Commonwealth University (VCU) team is developing immersive virtual reality “games” to help those with movement disorders, including Parkinson’s disease. Led by James S. Thomas, PhD, a physical therapy professor, the multidisciplinary science team at VCU’s Motor Control Lab in the College of Health Professions hope these…

Roche, Shape to Develop RNA-based Gene Therapies for Parkinson’s

Shape Therapeutics and Roche have entered into a strategic collaboration and license agreement to develop RNA-based gene therapies for Parkinson’s, Alzheimer’s, and rare diseases. Under the terms of the agreement, Shape will use its proprietary RNA technologies to leverage molecular machinery already present in human cells to…

Study Examines Proteins’ Roles in Mitochondrial Recycling

PINK1 and Parkin — two proteins whose deficiency has been linked to early-onset Parkinson’s — are involved in the degradation and recycling of mitochondria in neurons, a study shows. While these proteins were known to contribute to mitochondrial recycling in other cell types, this study provides a closer look into mitochondria’s…

Your Parkinson’s Community

Woman laying down illustration

Visit the Parkinson’s News Today forums to connect with others in the Parkinson’s community.

View Forums